Prognostic Value of PD-L1 Immunohistochemical Marker in Gastric Carcinoma and Its Correlation with HER2 Status

OBJECTIVE: Programmed death-ligand 1 (PD-L1) and human epidermal growth factor receptor 2 (HER2) are currently considered as prognostic markers and therapeutic targets in many human cancers. This study aims to evaluate immunohistochemical (IHC) expression of PD-L1 in gastric cancer (GC) and explore...

Descripción completa

Detalles Bibliográficos
Autores principales: Attia, Samar, Abd El Hafez, Amal, Abdel-Aziz, Azza, Elmetwaly, Shimaa, Mokhtar, Nagwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375601/
https://www.ncbi.nlm.nih.gov/pubmed/35485706
http://dx.doi.org/10.31557/APJCP.2022.23.4.1433

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375601/
https://www.ncbi.nlm.nih.gov/pubmed/35485706
http://dx.doi.org/10.31557/APJCP.2022.23.4.1433

Ejemplares similares